FADD adaptor in cancer

Léa Tourneur1, Agnès Buzyn, Gilles Chiocchia

  • 1Département d'Immunologie, Institut Cochin, INSERM U 567, CNRS UMR 8104, IFR 116, Université René Descartes, Paris V, Paris, France. chiocchia@cochin.inserm.fr.

Insights

Fas Associated protein with Death Domain (FADD) regulates cell death, survival, and proliferation. Defects in FADD expression are linked to tumor progression, offering potential therapeutic targets for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Fas Associated protein with Death Domain (FADD) is a crucial adaptor protein.
  • FADD mediates death receptor signaling and influences cell survival, proliferation, and cell cycle progression.
  • FADD's functions are modulated by cellular localization, phosphorylation, and inhibitory factors.

Purpose of the Study:

  • To review the multifaceted role of the FADD adaptor protein in cancer.
  • To explore the association between FADD expression defects and tumor progression.
  • To highlight the potential of understanding FADD regulation for cancer therapy and immune escape mechanisms.

Main Methods:

  • Literature review focusing on FADD's role in cancer.
  • Analysis of existing evidence on FADD expression in human and mouse tumors.
  • Synthesis of information on FADD regulatory mechanisms.

Main Results:

  • Defects in FADD protein expression are increasingly associated with tumor progression in both mice and humans.
  • FADD plays a complex role beyond just mediating cell death signals.
  • Dysregulation of FADD contributes to tumor growth and immune evasion.

Conclusions:

  • Understanding FADD regulation is vital for comprehending tumor development and immune escape.
  • Targeting FADD regulatory pathways may offer novel therapeutic strategies for cancer treatment.
  • Further research into FADD mechanisms can unlock new avenues for intervention.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...